Oxford Vaccine Expert Explains Hantavirus in Under 90 Seconds #OxfordUniversity
Why It Matters
Without funding, vaccine development lags, leaving travelers vulnerable and straining public‑health systems during zoonotic emergencies.
Key Takeaways
- •Hantavirus outbreak on cruise linked to Andes strain.
- •Asian/European hantavirus attacks kidneys; American strains target lungs.
- •Andes virus spreads via rodent droppings, causing severe respiratory illness.
- •Oxford researchers developing vaccines and therapeutics for hantavirus.
- •Funding essential for vaccine development and outbreak containment.
Summary
Oxford virologist Tess explains the current hantavirus outbreak aboard a cruise ship, identifying the culprit as the Andes virus, a strain native to the Americas.
She distinguishes two major hantavirus groups: Asian/European variants that damage kidneys, and North/South American strains that cause severe pulmonary disease. The Andes virus, transmitted through rodent excreta, is responsible for the cruise’s respiratory cases.
Tess emphasizes confidence in WHO and UK Health Security Agency actions, but stresses that vaccine and therapeutic development hinges on sustained funding. “We need resources to make vaccines, do research, and create therapeutics,” she says.
The episode underscores the urgency of investing in zoonotic disease countermeasures, as timely vaccine production could prevent future outbreaks and protect global travelers.
Comments
Want to join the conversation?
Loading comments...